<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04933604</url>
  </required_header>
  <id_info>
    <org_study_id>OMU KAEK 11.07.2019/538</org_study_id>
    <nct_id>NCT04933604</nct_id>
  </id_info>
  <brief_title>LPN in Patients With High-complex Renal Tumors</brief_title>
  <official_title>Comparison of Laparoscopic Partial Nephrectomy Versus Laparoscopic Radical Nephrectomy in Patients With High-Complexity Renal Tumors: A Propensity Score Matched Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsun Liv Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ondokuz Mayıs University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Samsun Liv Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the rationale for LPN in patients with high-complexity renal&#xD;
      tumors in terms of oncologic and functional outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From November 2009 to October 2018, 399 patients underwent LPN and 307 patients to&#xD;
      laparoscopic radical nephrectomy (LRN). 41 patients with RENAL score ≥ 10 enrolled in LPN and&#xD;
      265 patients to the LRN group. Propensity score matching (matched by age, gender, clinical&#xD;
      tumor stage, tumor size, baseline renal function, comorbidities such as diabetes mellitus&#xD;
      (DM), hypertension (HT), coronary artery disease (CAD), and final tumor pathology of RCC) was&#xD;
      used to reduce selection bias. Functional and oncological outcomes were compared between the&#xD;
      two groups. After propensity score analysis, 39 patients in the LRN group were matched with&#xD;
      39 in the LPN group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Actual">February 4, 2021</completion_date>
  <primary_completion_date type="Actual">May 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Operation time</measure>
    <time_frame>at the end of the surgery</time_frame>
    <description>time from onset to complete of surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood loss</measure>
    <time_frame>at the end of the surgery</time_frame>
    <description>amount of bleeding during surgery (mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>warm ischemia time</measure>
    <time_frame>at the and of the surgery</time_frame>
    <description>The clamp time of the renal artery and vein which is required to complete tumor excision and renorrhaphy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative complication</measure>
    <time_frame>up to 3 months postoperatively</time_frame>
    <description>abnormal problmes that may be seen after surgery and require additional intervention, treatment or follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>functional outcomes</measure>
    <time_frame>1 year after the surgery</time_frame>
    <description>serum creatinine level (mg /dL) and estimated glomerular filtration rate (CKD Epidemiology Collaboration (CKD-EPI) equation) (mL/min/1.73 m2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>surigcal margin status</measure>
    <time_frame>postoperative follow-up, through study completion, an average of 1 year</time_frame>
    <description>presence or absence of tumors at the surgical margin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CKD stage upgrading</measure>
    <time_frame>postoperative follow-up, through study completion, an average of 1 year</time_frame>
    <description>evaluation of preoperative and postoperative renal functions according to chronic kidney disease stages</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oncological outomes</measure>
    <time_frame>postoperative follow-up, through study completion, an average of 1 year</time_frame>
    <description>Presence or absence of local and/or distal tumor recurrence</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">78</enrollment>
  <condition>Renal Cancer</condition>
  <condition>Renal Neoplasm</condition>
  <condition>Renal Cell Carcinoma</condition>
  <condition>Surgery</condition>
  <condition>Oncology</condition>
  <condition>Kidney Ischemia</condition>
  <condition>Kidney Injury</condition>
  <condition>Urologic Neoplasms</condition>
  <condition>Urologic Cancer</condition>
  <condition>Kidney Neoplasms</condition>
  <arm_group>
    <arm_group_label>LPN group</arm_group_label>
    <description>39 patients with high complexity renal tumors who underwent laparoscopic partial nephrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LRN group</arm_group_label>
    <description>39 patients with high complexity renal tumors who underwent laparoscopic radical nephrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic partial nephrectomy</intervention_name>
    <description>Nephron sparing minimally invasive surgery</description>
    <arm_group_label>LPN group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic radical nephrectomy</intervention_name>
    <description>Completely removal of kidney by using laparoscopic surgery</description>
    <arm_group_label>LRN group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        From November 2009 to October 2018, 399 patients underwent LPN and 307 patients to&#xD;
        laparoscopic radical nephrectomy (LRN). 41 patients with RENAL score ≥ 10 enrolled in LPN&#xD;
        and 265 patients to the LRN group. Propensity score matching (matched by age, gender,&#xD;
        clinical tumor stage, tumor size, baseline renal function, comorbidities such as diabetes&#xD;
        mellitus (DM), hypertension (HT), coronary artery disease (CAD) and final tumor pathology&#xD;
        of RCC) was used to reduce selection bias. Functional and oncological outcomes were&#xD;
        compared between the two groups. After propensity score analysis, 39 patients in the LRN&#xD;
        group were matched with 39 in the LPN group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with complete data&#xD;
&#xD;
          -  Patients with single renal tumor on the effected side&#xD;
&#xD;
          -  Patients who approved the written consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who not approved the written consent form&#xD;
&#xD;
          -  Patients with incomplete data&#xD;
&#xD;
          -  Patients with low or mild complexity renal tumors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ender Ozden, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Üroloji Anabilim dalı</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Saban Sarıkaya, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Ondokuz Mayıs University, Faculty of Medicine, Department of Urology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mehmet Mercimek, MD, FEBU</last_name>
    <role>Principal Investigator</role>
    <affiliation>Liv Hospital Samsun, Department of Urology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yakup Bostancı, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ondokuz Mayıs University, Faculty of Medicine, Department of Urology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Murat Gulsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsun Gazi State Hospital, Departmen of Urology, Samsun, Turkey</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ondokuz Mayıs University, Department of Urology</name>
      <address>
        <city>Samsun</city>
        <zip>55020</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Kim SP, Campbell SC, Gill I, Lane BR, Van Poppel H, Smaldone MC, Volpe A, Kutikov A. Collaborative Review of Risk Benefit Trade-offs Between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses. Eur Urol. 2017 Jul;72(1):64-75. doi: 10.1016/j.eururo.2016.11.038. Epub 2016 Dec 14. Review.</citation>
    <PMID>27988238</PMID>
  </results_reference>
  <results_reference>
    <citation>Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7. Review.</citation>
    <PMID>27614693</PMID>
  </results_reference>
  <results_reference>
    <citation>Yang F, Zhou Q, Xing N. Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma. J Cancer Res Clin Oncol. 2020 Jan;146(1):261-272. doi: 10.1007/s00432-019-03058-z. Epub 2019 Nov 1.</citation>
    <PMID>31677114</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 31, 2021</study_first_submitted>
  <study_first_submitted_qc>June 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2021</study_first_posted>
  <last_update_submitted>June 13, 2021</last_update_submitted>
  <last_update_submitted_qc>June 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsun Liv Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Necmettin Mercimek</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Laparoscopy</keyword>
  <keyword>nephrometry score</keyword>
  <keyword>partial nephrectomy</keyword>
  <keyword>propensity score matching</keyword>
  <keyword>radical nephrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Urologic Neoplasms</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

